Abstract: A method for identifying a motif or a combination of motifs having a Boolean state of predetermined mutations in a set of sequences including a) aligning a set of sequences of ordered motifs represented by a single-character code, b) comparing a reference sequence with the set of sequences aligned in step (a), c) identifying motifs not having mutated simultaneously or motifs having mutated simultaneously at least once on at least one sequence of the set and not having mutated on another sequence of the set.

Abstract: A purified protein comprising a mechanosensitive potassium channel activated by at least one polyunsaturated fatty acid and riluzole and the use of said channels in drug screening.

Abstract: A double-strand oligonucleotide including two complementary oligonucleotide sequences forming a hybrid, each including at one of their 3? or 5? ends, one to five unpaired nucleotides forming single-strand ends extending beyond the hybrid, one of the oligonucleotide sequences being substantially complementary to a target sequence belonging to a DNA or RNA molecule to be specifically repressed, the target sequence belonging to a DNA or RNA molecule of a gene coding an angiogenic factor.

Abstract: The present invention relates to the use of an inhibitor of histone deacetylase for preparing a drug for the treatment or prevention of a disease resulting from the deficiency of an adult gene in an individual by the re-expression of the homologous fetal gene. The invention concerns in particular the treatment of dystrophies such as Duchenne's dystrophy or Becker's dystrophy in which the defective adult gene is the dystrophin gene and the homologous fetal gene is the utrophin gene.

Abstract: Methods for identifying a motif or a combination of motifs having a Boolean state of predetermined mutations in a set of sequences including a) aligning a set of sequences of ordered motifs represented by a single-character code, b) comparing a reference sequence with the set of sequences aligned in step (a), c) identifying motifs not having mutated simultaneously and/or motifs having mutated simultaneously at least once on at least one sequence of the set and not having mutated on another sequence of the set.

Abstract: A purified protein comprising a mechanosensitive potassium channel activated by at least one polyunsaturated fatty acid and riluzole and the use of said channels in drug screening.

Abstract: A peptide comprising one or more intramolecular bonds corresponding to formula (I): Xaa-Ca1-Xab-Ca2-Xac-Ca3-Xad-Ca4-Xae-Ca5-Ca6-Xaf ??(I), having antimicrobial properties and compositions containing them, notably for the preservation of foodstuffs.

Abstract: A mutant Fab fragment of the 13B8.2 anti-CD4 antibody that binds a CD4 molecule and includes a mutation of at least one residue in a position situated in the VH variable domain of the heavy chain and/or in a position situated in the V? variable domain of the light chain.

Abstract: A device for controlling propulsive gas mixing at an outlet of an aircraft jet engine, wherein propulsive jets are composed of a hot primary jet exiting from a nozzle of the jet engine and a secondary flux flowing between an external wall of the nozzle and an internal wall of the jet engine including a divergent trailing edge on the wall that generates conditions of a separation of the primary jet close to an existence limit value and a primary jet controller that enables control of passage of the primary jet from a separated state to a reattached state, and vice versa.

Abstract: A method for identifying a motif or a combination of motifs having a Boolean state of predetermined mutations in a set of sequences including a) aligning a set of sequences of ordered motifs represented by a single-character code, b) comparing a reference sequence with the set of sequences aligned in step (a), c) identifying motifs not having mutated simultaneously or motifs having mutated simultaneously at least once on at least one sequence of the set and not having mutated on another sequence of the set.

Abstract: A pharmaceutical composition for the treatment, prevention or diagnosis of a tumoral pathology comprising an active agent which stabilizes an actin network of a cellular cytoskeleton.

Abstract: The invention relates to a device for detecting chemical species present in a condensed medium, comprising means for determining the wavelength and the intensity values which are characteristic of electromagnetic transmission signals which are backscattered in response to a plurality of electromagnetic excitations, which have distinct wavelengths, of at least one chemical species which can be contained in the condensed medium; laser means producing a beam in order to excite the condensed medium; means for recording the wavelengths and the intensity values of backscattered electromagnetic transmission signals; and comparing and determining means for comparing the recorded intensity value of the electromagnetic signal, which is backscattered by the medium at a determined characteristic intensity value, with at least one corresponding transmission wavelength and excitation wave length.

Abstract: A Hall effect sensor formed in a multilayer structure including a thin active layer deposited on a substrate, wherein the substrate is an insulating, semi-insulating or semiconductor material of type p− or n+, respectively, to electrically isolate the active layer of the substrate and wherein the active layer is a weakly doped semiconductor material of type n− or p− in an exhaustion regime.